A Boston woman's call to a popular finance show reveals a marriage buckling under the weight of multi-million dollar real estate debt and conflicting risk appetites, highlighting how financial discord can threaten relationships.
In a stark episode of his show, personal finance expert Dave Ramsey labeled a husband's control over family finances as '100% abusive.' The case highlights how economic manipulation traps victims, a pattern experts say underpins nearly all domestic violence.
A Utah couple with a $180,000 income sought advice on using a $7,300 bonus. Dave Ramsey's firm counsel: shore up emergency savings, attack their HELOC debt, and postpone both a long-awaited honeymoon and speculative IPO investing until their financial foundation is secure.
A 24-year-old's father asked her to pay the premiums on his life insurance policy, framing it as an investment for her future. Personal finance expert Dave Ramsey and his co-host Ken Coleman weighed in on the emotional and financial pitfalls of such an arrangement.
New clinical imaging data for Molecular Partners' experimental radiotherapeutic MP0712, targeting the DLL3 protein in cancers like small cell lung cancer, show favorable tumor targeting and healthy organ clearance. The company confirms its U.S. Phase I/II trial is now open for patient screening.
Live cattle futures gained ground Friday, supported by steady cash trade, while feeder cattle contracts faced significant pressure. Market attention turns to the upcoming USDA Cattle Inventory report, expected to show a slight decline in total herd numbers.
A mail carrier in Lauderhill faces three counts of animal cruelty following the release of surveillance footage allegedly showing him spraying a resident's three small dogs with a chemical irritant during his delivery route.
Once a symbol of tech retrenchment, San Francisco's Showplace Square is undergoing a profound transformation. Major leases by AI firms Together AI and Physical Intelligence, coupled with Vanderbilt University's planned campus, are redefining the neighborhood as a nexus for technology, education, and innovation, offering a significant boost to the city's office recovery narrative.
Oppenheimer upgrades Relay Therapeutics (RLAY) to Outperform, citing the strength of its mutant-selective inhibitor pipeline and upcoming catalysts in the breast cancer treatment arena.
Amid a backdrop of cautious market optimism, companies with significant insider ownership are drawing investor attention. We examine three firms where those closest to the business are putting their money, spanning biotech, advanced semiconductors, and regional banking.
After a prolonged downturn, the pre-owned watch market saw a modest rebound in late 2025, driven largely by Patek Philippe and Rolex. However, a new report reveals a stark divide, with most brands still struggling with value retention as consumers pivot towards pragmatic purchases.
After a decade of development and multiple clinical setbacks, Sanofi's venglustat has met its primary goal in a Phase 3 trial for Type 3 Gaucher disease, offering new hope for neurological symptoms. The drug, however, failed a separate late-stage study for Fabry disease.
Internal correspondence reveals Coinbase co-founder Fred Ehrsam was personally briefed on and facilitated a multi-million dollar investment from the convicted sex offender, arranged by Tether's Brock Pierce.
Piper Sandler raises its price target on ImmunityBio, citing a near 700% surge in Anktiva sales and promising interim data from the QUILT trials that could support a major label expansion by 2027.
Seven Wisconsin employers filed WARN notices in January, yet the state's unemployment rate held steady at a low 3.1%. Economists point to a cooling but stable labor market, with significant workforce changes driven by retirements and sectoral shifts.
While broader UK indices face headwinds, a closer look reveals potential in smaller-cap companies. We examine three penny stocks—Alumasc Group, Mercia Asset Management, and Roebuck Food Group—that are navigating economic challenges with distinct strategies and financial profiles.
A newly surfaced 2014 email from the Jeffrey Epstein documents reveals Bitcoin-aligned executives warning investors about backing rival projects like Ripple. Some XRP proponents are framing the disclosure as validation of the token's early significance, though market momentum remains bearish.
With a partial government shutdown entering its third day, the House prepares to vote on a Senate-crafted funding deal. While Speaker Johnson eyes a Tuesday resolution, deep partisan divisions over Homeland Security funding and procedural hurdles threaten to prolong the stalemate, leaving thousands of federal employees working without pay.
Insiders at Canadian forestry giant Canfor Corporation have been net buyers of the company's shares over the last twelve months, with President Susan Yurkovich leading the activity. The trend signals internal optimism as key executives invest personal capital even above current trading prices.
Sanofi's experimental oral drug venglustat demonstrated significant neurological benefits for patients with Type 3 Gaucher disease in a late-stage trial, but failed to meet its primary endpoint in a separate study for Fabry disease, casting uncertainty on its regulatory path.
